Skip to content Skip to footer
Eltrombopag: Benefits, Reviews, Info, Side Effects!
Rx Details
Eltrombopag
Promacta, Revolade
Eltrombopag
Prescription
Medication
Drugs
Prescription Only
Increased platelet production, treatment of chronic immune thrombocytopenia, treatment of thrombocytopenia in patients with chronic hepatitis C, treatment of severe aplastic anemia, potential reduction in bleeding risk
Abdominal Pain, Back Pain, Cough, Diarrhea, Dizziness, Dry Mouth, Fatigue, Fever, Headache, Increased Liver Enzymes, Insomnia, Muscle Pain, Nausea, Rash, Upper Respiratory Tract Infection, Vomiting
Eltrombopag is a medication used to treat low blood platelet counts in certain conditions, such as chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia. The dosage of eltrombopag can vary based on the condition being treated, the patient’s age, and their response to the medication. For adults with chronic ITP, the typical starting dose is usually 50 mg once daily. However, for patients of East Asian descent, a lower starting dose of 25 mg once daily is often recommended due to differences in drug metabolism. The dose may be adjusted based on platelet count response, with a maximum dose of 75 mg per day. For patients with chronic hepatitis C-associated thrombocytopenia, the starting dose is also typically 25 mg once daily, with adjustments made based on platelet counts. In the case of severe aplastic anemia, the starting dose is usually 50 mg once daily, with adjustments based on response and tolerability. It’s important to note that these are general guidelines, and the exact dosage should be determined by a healthcare provider based on individual patient needs and circumstances. Always follow the prescribing information and consult with a healthcare professional for personalized advice.
Thrombocytopenia, aplastic anemia, chronic immune thrombocytopenic purpura (itp), hepatitis c-related thrombocytopenia
Eltrombopag has a generally favorable safety profile.
No Interactions Reported
$100 – $500
$1,500 for a 30day supply.

A Synopsis of

Eltrombopag

Eltrombopag is a medication that is commonly used to treat low platelet counts in patients with certain medical conditions. Platelets are essential for blood clotting and preventing excessive bleeding, so maintaining adequate platelet levels is crucial for overall health.

Eltrombopag works by stimulating the production of platelets in the bone marrow, helping to increase platelet counts and reduce the risk of bleeding episodes. It is often prescribed for patients with chronic immune thrombocytopenia (ITP), a condition where the immune system mistakenly attacks and destroys platelets, leading to low platelet counts.

It is important to follow your healthcare provider’s instructions when taking eltrombopag, as the dosage and duration of treatment may vary depending on your individual medical history and condition. It is typically taken once daily, with or without food, and should not be taken with certain medications that may interact with eltrombopag.

Like all medications, eltrombopag may cause side effects in some patients. Common side effects may include headache, nausea, diarrhea, and changes in taste. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Overall, eltrombopag can be an effective treatment option for patients with low platelet counts, helping to improve platelet levels and reduce the risk of bleeding complications. If you have been prescribed eltrombopag, be sure to discuss any questions or concerns with your healthcare provider to ensure safe and effective treatment.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN